AAAAAA
Results: 1-25/28
Authors:
Lamb, HM
Goa, KL
Citation: Hm. Lamb et Kl. Goa, Rivastigmine - A pharmacoeconomic review of its use in Alzheimer's disease, PHARMACOECO, 19(3), 2001, pp. 303-318
Authors:
Culy, CR
Lamb, HM
Citation: Cr. Culy et Hm. Lamb, I-131 tositumomab, BIODRUGS, 14(3), 2000, pp. 195-202
Authors:
Lamb, HM
Spencer, CM
Citation: Hm. Lamb et Cm. Spencer, Management of acute otitis media - Defining the role of cefuroxime axetil, DIS MANAG H, 8(6), 2000, pp. 337-353
Authors:
Matheson, AJ
Lamb, HM
Citation: Aj. Matheson et Hm. Lamb, Quetiapine - A review of its clinical potential in the management of psychotic symptoms in Parkinson's disease, CNS DRUGS, 14(2), 2000, pp. 157-172
Authors:
Hurst, M
Lamb, HM
Citation: M. Hurst et Hm. Lamb, Fluoxetine - A review of its use in anxiety disorders and mixed anxiety and depression, CNS DRUGS, 14(1), 2000, pp. 51-80
Authors:
Lamb, HM
Culy, CR
Faulds, D
Citation: Hm. Lamb et al., Inhaled fluticasone propionate - A pharmacoeconomic review of its use in the management of asthma, PHARMACOECO, 18(5), 2000, pp. 487-510
Authors:
Dooley, M
Lamb, HM
Citation: M. Dooley et Hm. Lamb, Donepezil - A review of its use in Alzheimer's disease, DRUG AGING, 16(3), 2000, pp. 199-226
Authors:
Lowe, MN
Lamb, HM
Citation: Mn. Lowe et Hm. Lamb, Meropenem - An updated review of its use in the management of intra-abdominal infections, DRUGS, 60(3), 2000, pp. 619-646
Authors:
Clemett, D
Lamb, HM
Citation: D. Clemett et Hm. Lamb, Exemestane - A review of its use in postmenopausal women with advanced breast cancer, DRUGS, 59(6), 2000, pp. 1279-1296
Authors:
Markham, A
Lamb, HM
Citation: A. Markham et Hm. Lamb, Infliximab - A review of its use in the management of rheumatoid arthritis, DRUGS, 59(6), 2000, pp. 1341-1359
Authors:
Lowe, MN
Lamb, HM
Citation: Mn. Lowe et Hm. Lamb, Gemifloxacin, DRUGS, 59(5), 2000, pp. 1137-1147
Authors:
Hurst, M
Lamb, HM
Citation: M. Hurst et Hm. Lamb, Meropenem - A review of its use in patients in intensive care, DRUGS, 59(3), 2000, pp. 653-680
Authors:
Comer, AM
Lamb, HM
Citation: Am. Comer et Hm. Lamb, Lidocaine patch 5%, DRUGS, 59(2), 2000, pp. 245-249
Authors:
Gillies, PS
Figgitt, DP
Lamb, HM
Citation: Ps. Gillies et al., Insulin glargine, DRUGS, 59(2), 2000, pp. 253-260
Authors:
Balfour, JAB
Lamb, HM
Citation: Jab. Balfour et Hm. Lamb, Moxifloxacin - A review of its clinical potential in the management of community-acquired respiratory tract infections, DRUGS, 59(1), 2000, pp. 115-139
Authors:
Hamilton, QUI
Lamb, HM
Hallett, C
Proctor, JA
Citation: Qui. Hamilton et al., Passive treatment systems for the remediation of acid mine drainage at Wheal Jane, Cornwall, J CHART I W, 13(2), 1999, pp. 93-103
Authors:
Plosker, GL
Lamb, HM
Citation: Gl. Plosker et Hm. Lamb, Diclofenac misoprostol - Pharmacoeconomic implications of therapy, PHARMACOECO, 16(1), 1999, pp. 85-98
Authors:
Onrust, SV
Lamb, HM
Citation: Sv. Onrust et Hm. Lamb, Valrubicin, DRUG AGING, 15(1), 1999, pp. 69-75
Authors:
Lamb, HM
Figgitt, DP
Faulds, D
Citation: Hm. Lamb et al., Quinupristin/dalfopristin - A review of its use in the management of serious Gram-positive infections, DRUGS, 58(6), 1999, pp. 1061-1097
Authors:
Perry, CM
Balfour, JAB
Lamb, HM
Citation: Cm. Perry et al., Gatifloxacin, DRUGS, 58(4), 1999, pp. 683-696
Authors:
Scott, LJ
Lamb, HM
Citation: Lj. Scott et Hm. Lamb, Rofecoxib, DRUGS, 58(3), 1999, pp. 499-505
Authors:
Langtry, HD
Lamb, HM
Citation: Hd. Langtry et Hm. Lamb, Levofloxacin: Its use in infections of the respiratory tract, skin, soft tissues and urinary tract (vol 56, pg 487, 1999), DRUGS, 58(2), 1999, pp. 296-296
Authors:
Scott, LJ
Lamb, HM
Citation: Lj. Scott et Hm. Lamb, Palivizumab, DRUGS, 58(2), 1999, pp. 305-311
Authors:
Perry, CM
Lamb, HM
Citation: Cm. Perry et Hm. Lamb, Topical imiquimod - A review of its use in genital warts, DRUGS, 58(2), 1999, pp. 375-390
Authors:
Onrust, SV
Lamb, HM
Balfour, JAB
Citation: Sv. Onrust et al., Rituximab, DRUGS, 58(1), 1999, pp. 79-88